

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.72354691 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 5.44564691 |
| 3 | chaperone-mediated protein transport (GO:0072321) | 4.87292518 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.72587977 |
| 5 | retinal cone cell development (GO:0046549) | 4.54588098 |
| 6 | sensory perception of smell (GO:0007608) | 4.43949126 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.02318067 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.02318067 |
| 9 | photoreceptor cell maintenance (GO:0045494) | 3.99631007 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.98392984 |
| 11 | rRNA modification (GO:0000154) | 3.93433517 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.92180126 |
| 13 | pseudouridine synthesis (GO:0001522) | 3.85247768 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 3.81328136 |
| 15 | GMP metabolic process (GO:0046037) | 3.77490670 |
| 16 | detection of light stimulus involved in visual perception (GO:0050908) | 3.64130048 |
| 17 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.64130048 |
| 18 | DNA replication checkpoint (GO:0000076) | 3.62439899 |
| 19 | protein targeting to mitochondrion (GO:0006626) | 3.53106513 |
| 20 | respiratory electron transport chain (GO:0022904) | 3.52656836 |
| 21 | ribosomal large subunit biogenesis (GO:0042273) | 3.51915012 |
| 22 | regulation of mitochondrial translation (GO:0070129) | 3.50636413 |
| 23 | electron transport chain (GO:0022900) | 3.49076349 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.48068598 |
| 25 | chromatin remodeling at centromere (GO:0031055) | 3.47889832 |
| 26 | GTP biosynthetic process (GO:0006183) | 3.47613904 |
| 27 | CENP-A containing nucleosome assembly (GO:0034080) | 3.47588074 |
| 28 | maturation of 5.8S rRNA (GO:0000460) | 3.45771216 |
| 29 | ribosome assembly (GO:0042255) | 3.42862655 |
| 30 | protein localization to cilium (GO:0061512) | 3.42454293 |
| 31 | sequestering of actin monomers (GO:0042989) | 3.42181502 |
| 32 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.39982950 |
| 33 | rRNA methylation (GO:0031167) | 3.38894160 |
| 34 | rRNA processing (GO:0006364) | 3.36578356 |
| 35 | photoreceptor cell development (GO:0042461) | 3.35919763 |
| 36 | purine nucleobase biosynthetic process (GO:0009113) | 3.35624673 |
| 37 | DNA deamination (GO:0045006) | 3.33400543 |
| 38 | transcription from mitochondrial promoter (GO:0006390) | 3.32769235 |
| 39 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.32360919 |
| 40 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.32360919 |
| 41 | rRNA metabolic process (GO:0016072) | 3.32179849 |
| 42 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.29205344 |
| 43 | protein complex biogenesis (GO:0070271) | 3.26852881 |
| 44 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.26626159 |
| 45 | nonmotile primary cilium assembly (GO:0035058) | 3.26324575 |
| 46 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.26099294 |
| 47 | ribosomal small subunit biogenesis (GO:0042274) | 3.25627149 |
| 48 | nucleobase biosynthetic process (GO:0046112) | 3.24083021 |
| 49 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21382872 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21382872 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21382872 |
| 52 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.20498631 |
| 53 | sensory perception of chemical stimulus (GO:0007606) | 3.19975655 |
| 54 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.19727135 |
| 55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.18685169 |
| 56 | termination of RNA polymerase III transcription (GO:0006386) | 3.18685169 |
| 57 | CTP biosynthetic process (GO:0006241) | 3.17576724 |
| 58 | CTP metabolic process (GO:0046036) | 3.17576724 |
| 59 | mitochondrial RNA metabolic process (GO:0000959) | 3.17351901 |
| 60 | protein localization to mitochondrion (GO:0070585) | 3.16660642 |
| 61 | snRNA transcription (GO:0009301) | 3.15905748 |
| 62 | eye photoreceptor cell development (GO:0042462) | 3.14694654 |
| 63 | DNA double-strand break processing (GO:0000729) | 3.14468793 |
| 64 | establishment of protein localization to mitochondrion (GO:0072655) | 3.13319736 |
| 65 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.12252599 |
| 66 | UTP biosynthetic process (GO:0006228) | 3.09870016 |
| 67 | olfactory bulb development (GO:0021772) | 3.08844150 |
| 68 | cellular component biogenesis (GO:0044085) | 3.08052814 |
| 69 | establishment of integrated proviral latency (GO:0075713) | 3.06526509 |
| 70 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.02610476 |
| 71 | protein insertion into membrane (GO:0051205) | 3.02522085 |
| 72 | intraciliary transport (GO:0042073) | 3.02402968 |
| 73 | translation (GO:0006412) | 3.02032458 |
| 74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.97785648 |
| 75 | spliceosomal snRNP assembly (GO:0000387) | 2.97549674 |
| 76 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.95351872 |
| 77 | proteasome assembly (GO:0043248) | 2.93542828 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93402508 |
| 79 | UTP metabolic process (GO:0046051) | 2.92569858 |
| 80 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.91985981 |
| 81 | base-excision repair, AP site formation (GO:0006285) | 2.91974938 |
| 82 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.91964002 |
| 83 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.91061175 |
| 84 | histone exchange (GO:0043486) | 2.89387046 |
| 85 | synapsis (GO:0007129) | 2.87379934 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.85388016 |
| 87 | respiratory chain complex IV assembly (GO:0008535) | 2.84836214 |
| 88 | histone mRNA metabolic process (GO:0008334) | 2.84196991 |
| 89 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.84196817 |
| 90 | intracellular protein transmembrane import (GO:0044743) | 2.83474336 |
| 91 | cellular response to virus (GO:0098586) | 2.83171087 |
| 92 | 7-methylguanosine mRNA capping (GO:0006370) | 2.81418053 |
| 93 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.80179761 |
| 94 | DNA damage response, detection of DNA damage (GO:0042769) | 2.79364627 |
| 95 | tRNA processing (GO:0008033) | 2.78813255 |
| 96 | 7-methylguanosine RNA capping (GO:0009452) | 2.77968076 |
| 97 | RNA capping (GO:0036260) | 2.77968076 |
| 98 | protein neddylation (GO:0045116) | 2.77578881 |
| 99 | replication fork processing (GO:0031297) | 2.77073105 |
| 100 | phototransduction (GO:0007602) | 2.76617188 |
| 101 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.76197979 |
| 102 | regulation of chromatin binding (GO:0035561) | 2.75177914 |
| 103 | histone H2A acetylation (GO:0043968) | 2.74749121 |
| 104 | DNA ligation (GO:0006266) | 2.74249530 |
| 105 | C-terminal protein lipidation (GO:0006501) | 2.74185784 |
| 106 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.73869749 |
| 107 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.73779988 |
| 108 | purine nucleotide salvage (GO:0032261) | 2.73672555 |
| 109 | cotranslational protein targeting to membrane (GO:0006613) | 2.73409488 |
| 110 | ncRNA processing (GO:0034470) | 2.73201692 |
| 111 | mitochondrial transport (GO:0006839) | 2.72448780 |
| 112 | ncRNA metabolic process (GO:0034660) | 2.71853526 |
| 113 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.71473929 |
| 114 | detection of visible light (GO:0009584) | 2.71355313 |
| 115 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.70873457 |
| 116 | detection of light stimulus (GO:0009583) | 2.70038506 |
| 117 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.69762745 |
| 118 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69708724 |
| 119 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69708724 |
| 120 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69708724 |
| 121 | oxidative phosphorylation (GO:0006119) | 2.68948981 |
| 122 | cytochrome complex assembly (GO:0017004) | 2.66991333 |
| 123 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.66769754 |
| 124 | cullin deneddylation (GO:0010388) | 2.65963497 |
| 125 | phototransduction, visible light (GO:0007603) | 2.65904050 |
| 126 | axon ensheathment in central nervous system (GO:0032291) | 2.62604309 |
| 127 | central nervous system myelination (GO:0022010) | 2.62604309 |
| 128 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.62205173 |
| 129 | natural killer cell mediated immunity (GO:0002228) | 2.62205173 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.61703561 |
| 131 | interferon-gamma production (GO:0032609) | 2.60273340 |
| 132 | establishment of viral latency (GO:0019043) | 2.57096556 |
| 133 | visual perception (GO:0007601) | 2.54903103 |
| 134 | negative regulation of mast cell activation (GO:0033004) | 2.53432146 |
| 135 | viral mRNA export from host cell nucleus (GO:0046784) | 2.52953231 |
| 136 | protein deneddylation (GO:0000338) | 2.52101871 |
| 137 | sensory perception of light stimulus (GO:0050953) | 2.51814458 |
| 138 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.51389604 |
| 139 | peptidyl-histidine modification (GO:0018202) | 2.50339710 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.45762668 |
| 141 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.45487895 |
| 142 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.45461152 |
| 143 | protein polyglutamylation (GO:0018095) | 2.44475132 |
| 144 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.44320372 |
| 145 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.44150777 |
| 146 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.44140010 |
| 147 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.44140010 |
| 148 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.43351948 |
| 149 | protein-chromophore linkage (GO:0018298) | 2.43247751 |
| 150 | DNA strand elongation (GO:0022616) | 2.42685220 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.42447367 |
| 152 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 2.41786600 |
| 153 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.40540479 |
| 154 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.39721020 |
| 155 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.37488647 |
| 156 | negative regulation of ligase activity (GO:0051352) | 2.36506562 |
| 157 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.36506562 |
| 158 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.35809968 |
| 159 | regulation of guanylate cyclase activity (GO:0031282) | 2.35590455 |
| 160 | deoxyribonucleotide catabolic process (GO:0009264) | 2.34176531 |
| 161 | organelle disassembly (GO:1903008) | 2.33678314 |
| 162 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.33554856 |
| 163 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.33511508 |
| 164 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.31500274 |
| 165 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.30727394 |
| 166 | neutrophil activation involved in immune response (GO:0002283) | 2.30074997 |
| 167 | megakaryocyte development (GO:0035855) | 2.29837810 |
| 168 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.29467309 |
| 169 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.29467309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.82889341 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.45436533 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.29216600 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.26628580 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.24492395 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16647407 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99277914 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91480068 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.71961786 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64810898 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64794207 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.64197608 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.28448426 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23207265 |
| 15 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.17781066 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15182888 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.12987082 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.05424927 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.05073473 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97171054 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.97023118 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.96511031 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.92888039 |
| 24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.91921902 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88959073 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88016487 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86090459 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.84780319 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84500199 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83315625 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82769548 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.81048222 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77426326 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75463849 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73106204 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.70176934 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.70045247 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.69215921 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69006503 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62322398 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.62297108 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.57209144 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55747500 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55738614 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52616831 |
| 46 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51923548 |
| 47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51632296 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51499386 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49506464 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48635655 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47817827 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44135468 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42310462 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41771279 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40868848 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40545200 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38825653 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38110358 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37598868 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37502943 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37226988 |
| 62 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37078730 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.35683808 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33667465 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31318710 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29226670 |
| 67 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26052055 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25210328 |
| 69 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25175805 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23917196 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23664939 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22202046 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21143731 |
| 74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.21022066 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20870218 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19783415 |
| 77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18650186 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16725045 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16016623 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14953663 |
| 81 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14774425 |
| 82 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.12673794 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12641639 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11451336 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11036021 |
| 86 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10590932 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09073805 |
| 88 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05686547 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04642282 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04632668 |
| 91 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03261479 |
| 92 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02967769 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02013053 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01677261 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00207031 |
| 96 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00135982 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00029781 |
| 98 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99516588 |
| 99 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.99032513 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98334642 |
| 101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.98238131 |
| 102 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98208024 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96208696 |
| 104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96142235 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95240368 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93607915 |
| 107 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93607915 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93251895 |
| 109 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91184777 |
| 110 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90663519 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90284072 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90203608 |
| 113 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90101372 |
| 114 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89571328 |
| 115 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89269098 |
| 116 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88861050 |
| 117 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88329028 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87051129 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86979528 |
| 120 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86098417 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86084476 |
| 122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85079529 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84990304 |
| 124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83867657 |
| 125 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83557450 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82688076 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82217642 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.82195385 |
| 129 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80951467 |
| 130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.80705660 |
| 131 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79052616 |
| 132 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.78526680 |
| 133 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77648412 |
| 134 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77373149 |
| 135 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.77201350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 4.90437133 |
| 2 | MP0008789_abnormal_olfactory_epithelium | 3.73247411 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 3.49461683 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.42364932 |
| 5 | MP0005394_taste/olfaction_phenotype | 3.17943863 |
| 6 | MP0005499_abnormal_olfactory_system | 3.17943863 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.79272024 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 2.45826906 |
| 9 | MP0005253_abnormal_eye_physiology | 2.43017507 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.37802685 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.35236663 |
| 12 | MP0003195_calcinosis | 2.18286849 |
| 13 | MP0008058_abnormal_DNA_repair | 2.18013333 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.16369841 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.07630531 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.06062252 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.01455331 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.00036420 |
| 19 | MP0001188_hyperpigmentation | 1.99292909 |
| 20 | MP0003718_maternal_effect | 1.98075700 |
| 21 | MP0003123_paternal_imprinting | 1.95213036 |
| 22 | MP0004147_increased_porphyrin_level | 1.94342618 |
| 23 | MP0005670_abnormal_white_adipose | 1.91546472 |
| 24 | MP0003011_delayed_dark_adaptation | 1.85092087 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.83225297 |
| 26 | MP0009697_abnormal_copulation | 1.77950960 |
| 27 | MP0003786_premature_aging | 1.77656462 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76837477 |
| 29 | MP0005671_abnormal_response_to | 1.73556611 |
| 30 | MP0009785_altered_susceptibility_to | 1.70996693 |
| 31 | MP0008057_abnormal_DNA_replication | 1.68554921 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.67440538 |
| 33 | MP0002160_abnormal_reproductive_system | 1.66165104 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.61329971 |
| 35 | MP0010094_abnormal_chromosome_stability | 1.57165871 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.56771054 |
| 37 | MP0003941_abnormal_skin_development | 1.56604042 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.53519037 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.51015025 |
| 40 | MP0003890_abnormal_embryonic-extraembry | 1.48123031 |
| 41 | MP0001542_abnormal_bone_strength | 1.46816930 |
| 42 | MP0005195_abnormal_posterior_eye | 1.43908803 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.42656624 |
| 44 | MP0003787_abnormal_imprinting | 1.42600210 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.41307180 |
| 46 | MP0005410_abnormal_fertilization | 1.39740983 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.39575748 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.36369554 |
| 49 | MP0005171_absent_coat_pigmentation | 1.36024037 |
| 50 | MP0002752_abnormal_somatic_nervous | 1.35897516 |
| 51 | MP0001905_abnormal_dopamine_level | 1.35786058 |
| 52 | MP0002184_abnormal_innervation | 1.33529514 |
| 53 | MP0005391_vision/eye_phenotype | 1.33129718 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.33059796 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.31786433 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.31473914 |
| 57 | MP0002102_abnormal_ear_morphology | 1.29595707 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.27442017 |
| 59 | MP0000490_abnormal_crypts_of | 1.26910582 |
| 60 | MP0008260_abnormal_autophagy | 1.26126088 |
| 61 | MP0003880_abnormal_central_pattern | 1.26104151 |
| 62 | * MP0003763_abnormal_thymus_physiology | 1.25651230 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.21048834 |
| 64 | MP0004742_abnormal_vestibular_system | 1.20905418 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.18431869 |
| 66 | MP0005332_abnormal_amino_acid | 1.18181164 |
| 67 | MP0001293_anophthalmia | 1.16511904 |
| 68 | MP0006054_spinal_hemorrhage | 1.14618280 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.13152821 |
| 70 | * MP0001819_abnormal_immune_cell | 1.11674416 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.11234271 |
| 72 | MP0005025_abnormal_response_to | 1.11191307 |
| 73 | * MP0002420_abnormal_adaptive_immunity | 1.10935283 |
| 74 | MP0002723_abnormal_immune_serum | 1.08891924 |
| 75 | * MP0002452_abnormal_antigen_presenting | 1.08395128 |
| 76 | MP0002210_abnormal_sex_determination | 1.08135998 |
| 77 | MP0001929_abnormal_gametogenesis | 1.07956457 |
| 78 | MP0002090_abnormal_vision | 1.06073135 |
| 79 | MP0002132_abnormal_respiratory_system | 1.05628576 |
| 80 | MP0001853_heart_inflammation | 1.05042664 |
| 81 | MP0003136_yellow_coat_color | 1.04548675 |
| 82 | MP0003724_increased_susceptibility_to | 1.04420331 |
| 83 | MP0000778_abnormal_nervous_system | 1.04151232 |
| 84 | MP0001529_abnormal_vocalization | 1.03511982 |
| 85 | MP0002272_abnormal_nervous_system | 1.03204944 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.03151578 |
| 87 | MP0003077_abnormal_cell_cycle | 1.02511791 |
| 88 | MP0002229_neurodegeneration | 1.02216446 |
| 89 | MP0001145_abnormal_male_reproductive | 1.01888596 |
| 90 | MP0002419_abnormal_innate_immunity | 1.01670075 |
| 91 | MP0002398_abnormal_bone_marrow | 1.00457963 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.99406052 |
| 93 | MP0003937_abnormal_limbs/digits/tail_de | 0.99334628 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.99276365 |
| 95 | MP0006082_CNS_inflammation | 0.99102232 |
| 96 | MP0009046_muscle_twitch | 0.98744595 |
| 97 | MP0001800_abnormal_humoral_immune | 0.98341402 |
| 98 | MP0001919_abnormal_reproductive_system | 0.97938929 |
| 99 | MP0008872_abnormal_physiological_respon | 0.97377226 |
| 100 | MP0000653_abnormal_sex_gland | 0.95709449 |
| 101 | MP0004133_heterotaxia | 0.95370769 |
| 102 | MP0008007_abnormal_cellular_replicative | 0.94997783 |
| 103 | MP0005389_reproductive_system_phenotype | 0.94657002 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.94058151 |
| 105 | MP0002736_abnormal_nociception_after | 0.93409287 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.92780732 |
| 107 | MP0000358_abnormal_cell_content/ | 0.91783480 |
| 108 | MP0003698_abnormal_male_reproductive | 0.91465556 |
| 109 | MP0002928_abnormal_bile_duct | 0.91408973 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.90635561 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.90455077 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.89049124 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.88390174 |
| 114 | MP0000716_abnormal_immune_system | 0.88262835 |
| 115 | MP0000516_abnormal_urinary_system | 0.87973413 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.87973413 |
| 117 | MP0000049_abnormal_middle_ear | 0.87415285 |
| 118 | MP0003436_decreased_susceptibility_to | 0.87289328 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.86935110 |
| 120 | MP0002938_white_spotting | 0.86178432 |
| 121 | MP0003252_abnormal_bile_duct | 0.86120985 |
| 122 | MP0003121_genomic_imprinting | 0.85936147 |
| 123 | MP0001764_abnormal_homeostasis | 0.85894608 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85715940 |
| 125 | MP0000647_abnormal_sebaceous_gland | 0.85586963 |
| 126 | MP0004142_abnormal_muscle_tone | 0.84863553 |
| 127 | MP0003186_abnormal_redox_activity | 0.84663679 |
| 128 | MP0005647_abnormal_sex_gland | 0.83593940 |
| 129 | MP0002163_abnormal_gland_morphology | 0.82415594 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.82201712 |
| 131 | MP0002735_abnormal_chemical_nociception | 0.82161112 |
| 132 | MP0001790_abnormal_immune_system | 0.82097132 |
| 133 | MP0005387_immune_system_phenotype | 0.82097132 |
| 134 | MP0000383_abnormal_hair_follicle | 0.81282449 |
| 135 | MP0002277_abnormal_respiratory_mucosa | 0.80646994 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.79867150 |
| 137 | MP0010678_abnormal_skin_adnexa | 0.79411478 |
| 138 | MP0005310_abnormal_salivary_gland | 0.78593191 |
| 139 | MP0002751_abnormal_autonomic_nervous | 0.77773517 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.76954068 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.76880104 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.76756543 |
| 143 | MP0009250_abnormal_appendicular_skeleto | 0.75797962 |
| 144 | MP0000427_abnormal_hair_cycle | 0.75381688 |
| 145 | MP0001502_abnormal_circadian_rhythm | 0.74978664 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.74484489 |
| 147 | MP0001730_embryonic_growth_arrest | 0.74210278 |
| 148 | MP0002429_abnormal_blood_cell | 0.73121934 |
| 149 | MP0002282_abnormal_trachea_morphology | 0.73058121 |
| 150 | MP0005408_hypopigmentation | 0.72972722 |
| 151 | MP0000026_abnormal_inner_ear | 0.72753965 |
| 152 | MP0002405_respiratory_system_inflammati | 0.72384798 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.71586596 |
| 154 | MP0002653_abnormal_ependyma_morphology | 0.71163994 |
| 155 | MP0003111_abnormal_nucleus_morphology | 0.71063507 |
| 156 | MP0003646_muscle_fatigue | 0.69244199 |
| 157 | MP0005187_abnormal_penis_morphology | 0.68788055 |
| 158 | MP0002177_abnormal_outer_ear | 0.68572435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 5.54478569 |
| 2 | Congenital stationary night blindness (HP:0007642) | 5.43909114 |
| 3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.16992952 |
| 4 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.94570185 |
| 5 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.81123665 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 4.52095367 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 4.47626269 |
| 8 | Pendular nystagmus (HP:0012043) | 4.03798017 |
| 9 | Medial flaring of the eyebrow (HP:0010747) | 3.97570293 |
| 10 | Gait imbalance (HP:0002141) | 3.89192882 |
| 11 | Congenital primary aphakia (HP:0007707) | 3.87074193 |
| 12 | Nephrogenic diabetes insipidus (HP:0009806) | 3.73188200 |
| 13 | Decreased central vision (HP:0007663) | 3.60587845 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.51818784 |
| 15 | True hermaphroditism (HP:0010459) | 3.49809787 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.40501125 |
| 17 | Choroideremia (HP:0001139) | 3.24875360 |
| 18 | Severe visual impairment (HP:0001141) | 3.24782034 |
| 19 | Cerebral edema (HP:0002181) | 3.12876155 |
| 20 | Hepatic necrosis (HP:0002605) | 3.06029698 |
| 21 | Hypothermia (HP:0002045) | 3.05551697 |
| 22 | Central scotoma (HP:0000603) | 3.00423356 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.00087489 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 3.00087489 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 2.99795007 |
| 26 | Acute necrotizing encephalopathy (HP:0006965) | 2.95684477 |
| 27 | Generalized aminoaciduria (HP:0002909) | 2.92746953 |
| 28 | Optic disc pallor (HP:0000543) | 2.86410254 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.85449229 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.85449229 |
| 31 | Constricted visual fields (HP:0001133) | 2.81008324 |
| 32 | Renal cortical cysts (HP:0000803) | 2.80076138 |
| 33 | Poor coordination (HP:0002370) | 2.79394253 |
| 34 | Genital tract atresia (HP:0001827) | 2.75765952 |
| 35 | Pancreatic cysts (HP:0001737) | 2.75412319 |
| 36 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.75133112 |
| 37 | Photophobia (HP:0000613) | 2.73869492 |
| 38 | Degeneration of anterior horn cells (HP:0002398) | 2.73512522 |
| 39 | Abnormality of the anterior horn cell (HP:0006802) | 2.73512522 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.70258130 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.70258130 |
| 42 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.68478317 |
| 43 | Retinitis pigmentosa (HP:0000510) | 2.64285458 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.64268866 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63409558 |
| 46 | Vaginal atresia (HP:0000148) | 2.62684281 |
| 47 | Lactic acidosis (HP:0003128) | 2.61192307 |
| 48 | Respiratory failure (HP:0002878) | 2.57175699 |
| 49 | Abnormal ciliary motility (HP:0012262) | 2.56620223 |
| 50 | Decreased testicular size (HP:0008734) | 2.52905797 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.52066161 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.50406071 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.50406071 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.50406071 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.50406071 |
| 56 | Microvesicular hepatic steatosis (HP:0001414) | 2.50157931 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.43435984 |
| 58 | Abnormality of the renal cortex (HP:0011035) | 2.42764265 |
| 59 | Scotoma (HP:0000575) | 2.42743274 |
| 60 | Retinal dysplasia (HP:0007973) | 2.29731839 |
| 61 | Respiratory difficulties (HP:0002880) | 2.29409757 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.29150050 |
| 63 | Glycosuria (HP:0003076) | 2.29150050 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.27289626 |
| 65 | Abnormal hair whorl (HP:0010721) | 2.27135933 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.25184598 |
| 67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24823958 |
| 68 | Lethargy (HP:0001254) | 2.22689622 |
| 69 | Renal Fanconi syndrome (HP:0001994) | 2.18619701 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.18427754 |
| 71 | Optic neuritis (HP:0100653) | 2.18427754 |
| 72 | Anencephaly (HP:0002323) | 2.16819245 |
| 73 | Type II lissencephaly (HP:0007260) | 2.15513215 |
| 74 | Increased IgM level (HP:0003496) | 2.13220369 |
| 75 | Birth length less than 3rd percentile (HP:0003561) | 2.13196083 |
| 76 | Rhinitis (HP:0012384) | 2.12469971 |
| 77 | Increased CSF lactate (HP:0002490) | 2.11424639 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.09512024 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.09082985 |
| 80 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08508998 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 2.08424537 |
| 82 | Type II diabetes mellitus (HP:0005978) | 2.07024790 |
| 83 | Increased serum pyruvate (HP:0003542) | 2.06823386 |
| 84 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05747287 |
| 85 | Keratoconus (HP:0000563) | 2.00494790 |
| 86 | Increased corneal curvature (HP:0100692) | 2.00494790 |
| 87 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00136163 |
| 88 | Exercise intolerance (HP:0003546) | 1.99926890 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 1.99341279 |
| 90 | Methylmalonic aciduria (HP:0012120) | 1.99284803 |
| 91 | Optic nerve coloboma (HP:0000588) | 1.97885344 |
| 92 | Nephronophthisis (HP:0000090) | 1.97301143 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 1.97051033 |
| 94 | Anosmia (HP:0000458) | 1.96946434 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 1.96750571 |
| 96 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.96626368 |
| 97 | Limb dystonia (HP:0002451) | 1.96487457 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.96195249 |
| 99 | Macrocytic anemia (HP:0001972) | 1.95850223 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.95760915 |
| 101 | Exertional dyspnea (HP:0002875) | 1.95086469 |
| 102 | Hepatocellular necrosis (HP:0001404) | 1.94637794 |
| 103 | Abnormality of the pons (HP:0007361) | 1.94465782 |
| 104 | Abnormality of serum amino acid levels (HP:0003112) | 1.93898816 |
| 105 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.93392214 |
| 106 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93325521 |
| 107 | Abnormality of chromosome stability (HP:0003220) | 1.92779065 |
| 108 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.92411672 |
| 109 | Hyperglycinemia (HP:0002154) | 1.92071182 |
| 110 | Acute encephalopathy (HP:0006846) | 1.91997740 |
| 111 | Aplastic anemia (HP:0001915) | 1.91741526 |
| 112 | Stenosis of the external auditory canal (HP:0000402) | 1.91556238 |
| 113 | Preaxial hand polydactyly (HP:0001177) | 1.91541434 |
| 114 | Postaxial foot polydactyly (HP:0001830) | 1.91441391 |
| 115 | Hyperalaninemia (HP:0003348) | 1.86882618 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86882618 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 1.86882618 |
| 118 | Postaxial hand polydactyly (HP:0001162) | 1.85505466 |
| 119 | Aganglionic megacolon (HP:0002251) | 1.84637337 |
| 120 | Sclerocornea (HP:0000647) | 1.84341526 |
| 121 | Leukodystrophy (HP:0002415) | 1.83676684 |
| 122 | Abnormality of the preputium (HP:0100587) | 1.83083426 |
| 123 | Petechiae (HP:0000967) | 1.83021192 |
| 124 | Meckel diverticulum (HP:0002245) | 1.81508727 |
| 125 | CNS demyelination (HP:0007305) | 1.81275456 |
| 126 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80958953 |
| 127 | Abnormality of renal resorption (HP:0011038) | 1.80060953 |
| 128 | Median cleft lip (HP:0000161) | 1.79592681 |
| 129 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.79277162 |
| 130 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.79166478 |
| 131 | Thyroiditis (HP:0100646) | 1.78571861 |
| 132 | Hyperglycinuria (HP:0003108) | 1.78101932 |
| 133 | Volvulus (HP:0002580) | 1.78037564 |
| 134 | Cystic liver disease (HP:0006706) | 1.77201471 |
| 135 | Muscle fiber atrophy (HP:0100295) | 1.77122204 |
| 136 | Absent thumb (HP:0009777) | 1.76981736 |
| 137 | Male pseudohermaphroditism (HP:0000037) | 1.76878569 |
| 138 | Abnormality of the ileum (HP:0001549) | 1.76848877 |
| 139 | Chromsome breakage (HP:0040012) | 1.75462281 |
| 140 | Patchy hypopigmentation of hair (HP:0011365) | 1.73833267 |
| 141 | Furrowed tongue (HP:0000221) | 1.71368962 |
| 142 | Astigmatism (HP:0000483) | 1.71113435 |
| 143 | Bifid tongue (HP:0010297) | 1.71013267 |
| 144 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70937769 |
| 145 | Broad foot (HP:0001769) | 1.70853284 |
| 146 | Macular degeneration (HP:0000608) | 1.69910799 |
| 147 | Lipid accumulation in hepatocytes (HP:0006561) | 1.69028234 |
| 148 | Reticulocytopenia (HP:0001896) | 1.68767929 |
| 149 | Testicular atrophy (HP:0000029) | 1.68752224 |
| 150 | Abnormality of macrophages (HP:0004311) | 1.67780266 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65521714 |
| 152 | Increased serum lactate (HP:0002151) | 1.63843138 |
| 153 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.63624581 |
| 154 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.63624581 |
| 155 | Premature graying of hair (HP:0002216) | 1.63322425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.56863991 |
| 2 | PBK | 3.00243385 |
| 3 | STK16 | 2.99383694 |
| 4 | VRK2 | 2.71595791 |
| 5 | SIK3 | 2.70550124 |
| 6 | TXK | 2.69324620 |
| 7 | NEK1 | 2.51981032 |
| 8 | ERBB3 | 2.51579022 |
| 9 | PDK2 | 2.51253863 |
| 10 | PIM2 | 2.40702248 |
| 11 | IRAK4 | 2.40026356 |
| 12 | ARAF | 2.39472020 |
| 13 | GRK1 | 2.35031869 |
| 14 | SRPK1 | 2.11865653 |
| 15 | TRIM28 | 2.07028353 |
| 16 | MAP2K7 | 2.00353410 |
| 17 | BMPR2 | 1.99063018 |
| 18 | MKNK1 | 1.94381239 |
| 19 | CASK | 1.81329198 |
| 20 | VRK1 | 1.77141723 |
| 21 | EIF2AK3 | 1.72394149 |
| 22 | MKNK2 | 1.71991638 |
| 23 | MAPK13 | 1.66996917 |
| 24 | NUAK1 | 1.66159818 |
| 25 | IRAK2 | 1.66125938 |
| 26 | PLK4 | 1.59075635 |
| 27 | CDC7 | 1.56923943 |
| 28 | TNIK | 1.54891522 |
| 29 | BRSK2 | 1.48575070 |
| 30 | TEC | 1.44538900 |
| 31 | MAP3K14 | 1.43919725 |
| 32 | BUB1 | 1.43293800 |
| 33 | ZAK | 1.42627887 |
| 34 | MAP3K12 | 1.42566910 |
| 35 | STK39 | 1.39149466 |
| 36 | TAF1 | 1.36713624 |
| 37 | NME1 | 1.33068362 |
| 38 | DYRK2 | 1.29841912 |
| 39 | BRAF | 1.29370267 |
| 40 | DYRK3 | 1.28614373 |
| 41 | CSNK1G3 | 1.27607356 |
| 42 | MST4 | 1.27539926 |
| 43 | EIF2AK2 | 1.25614695 |
| 44 | YES1 | 1.19494880 |
| 45 | BCKDK | 1.14986483 |
| 46 | WNK3 | 1.07805989 |
| 47 | WNK4 | 1.07039271 |
| 48 | MAPKAPK5 | 1.06882700 |
| 49 | IRAK1 | 1.05770222 |
| 50 | RPS6KA4 | 1.05695431 |
| 51 | NLK | 1.04636332 |
| 52 | EIF2AK1 | 1.01998098 |
| 53 | IKBKE | 1.00386938 |
| 54 | OXSR1 | 0.99772239 |
| 55 | CSNK1A1L | 0.99503987 |
| 56 | RPS6KA5 | 0.99401781 |
| 57 | NEK2 | 0.97910910 |
| 58 | BCR | 0.94349588 |
| 59 | PLK2 | 0.93866778 |
| 60 | INSRR | 0.93594241 |
| 61 | STK10 | 0.93401955 |
| 62 | BMPR1B | 0.92283497 |
| 63 | CDK19 | 0.91490341 |
| 64 | CCNB1 | 0.86730837 |
| 65 | STK38L | 0.84616389 |
| 66 | MAP4K2 | 0.84542823 |
| 67 | ACVR1B | 0.83418689 |
| 68 | CSNK1G2 | 0.81147606 |
| 69 | PNCK | 0.80438300 |
| 70 | KDR | 0.80002422 |
| 71 | AURKB | 0.79158886 |
| 72 | CSNK1G1 | 0.77884107 |
| 73 | AURKA | 0.76757692 |
| 74 | DAPK1 | 0.75138215 |
| 75 | ADRBK2 | 0.74578181 |
| 76 | MUSK | 0.74315011 |
| 77 | MAPKAPK3 | 0.73132364 |
| 78 | CAMK2B | 0.70307098 |
| 79 | PLK3 | 0.69505411 |
| 80 | TGFBR1 | 0.67783860 |
| 81 | ATR | 0.66488093 |
| 82 | BRSK1 | 0.65275815 |
| 83 | ABL2 | 0.63571852 |
| 84 | ATM | 0.61936240 |
| 85 | IKBKB | 0.61668086 |
| 86 | ILK | 0.60399450 |
| 87 | IRAK3 | 0.60383031 |
| 88 | CAMK2D | 0.59198259 |
| 89 | NME2 | 0.59025946 |
| 90 | RPS6KB1 | 0.58294358 |
| 91 | SYK | 0.58251421 |
| 92 | KIT | 0.57952146 |
| 93 | PRKCI | 0.57920635 |
| 94 | CDK3 | 0.56845206 |
| 95 | BTK | 0.56742629 |
| 96 | CLK1 | 0.56421509 |
| 97 | BLK | 0.56393799 |
| 98 | NEK6 | 0.56044467 |
| 99 | CHUK | 0.55285042 |
| 100 | CDK8 | 0.55111703 |
| 101 | WEE1 | 0.55016822 |
| 102 | CSNK2A1 | 0.54958720 |
| 103 | MAP2K6 | 0.54740491 |
| 104 | TLK1 | 0.54539325 |
| 105 | MARK3 | 0.54424927 |
| 106 | CHEK2 | 0.54305466 |
| 107 | LYN | 0.54119338 |
| 108 | STK3 | 0.52908153 |
| 109 | CSNK1E | 0.51170646 |
| 110 | LIMK1 | 0.50689366 |
| 111 | TTK | 0.50421821 |
| 112 | PINK1 | 0.49072571 |
| 113 | CAMK2G | 0.49039899 |
| 114 | PIM1 | 0.48544069 |
| 115 | ADRBK1 | 0.48219373 |
| 116 | PRPF4B | 0.48025138 |
| 117 | MAP3K4 | 0.47994842 |
| 118 | PLK1 | 0.47400232 |
| 119 | GRK7 | 0.47005550 |
| 120 | CHEK1 | 0.46919394 |
| 121 | FES | 0.46271737 |
| 122 | PRKCG | 0.44564518 |
| 123 | MAP3K6 | 0.43870480 |
| 124 | TBK1 | 0.43430319 |
| 125 | SIK2 | 0.43072808 |
| 126 | RAF1 | 0.42535624 |
| 127 | MARK1 | 0.42519804 |
| 128 | RPS6KB2 | 0.42040184 |
| 129 | PRKCE | 0.41207709 |
| 130 | TSSK6 | 0.41163895 |
| 131 | CSNK2A2 | 0.39680800 |
| 132 | TRPM7 | 0.39674748 |
| 133 | GRK5 | 0.39573062 |
| 134 | RIPK4 | 0.39384709 |
| 135 | MAPKAPK2 | 0.37061450 |
| 136 | PRKCD | 0.35710585 |
| 137 | CDK7 | 0.34731841 |
| 138 | MAPK15 | 0.32819083 |
| 139 | CSNK1A1 | 0.29041109 |
| 140 | ERBB4 | 0.28703829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.08351037 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.05576855 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.83497865 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.57759812 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.43974026 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.32657258 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.20492577 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.18079990 |
| 9 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.05822440 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.98940220 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 1.92462570 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.91198250 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.88399609 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79509467 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.74750821 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65147170 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64473805 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63473346 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.62330014 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.58405206 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56179759 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55171804 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53033987 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44376701 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43893702 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41070400 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38648876 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.35934077 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33594044 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.31167635 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.30979164 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29659108 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.29181066 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26472675 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.25916289 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19859633 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16424189 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16299640 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15048986 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14238990 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11460005 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10329281 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.09629718 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07706961 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.06452213 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.06292159 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05521652 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03309364 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01793879 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01224970 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99319159 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98426212 |
| 53 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95517035 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94785064 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94719327 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93912519 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93713018 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93437049 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92705401 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92567278 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92217443 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91695359 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90885857 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.90700923 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90625773 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.89999498 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89912177 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88053402 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87751053 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87021178 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86254032 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86234938 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.85650729 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85217391 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85075926 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84909609 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.84279554 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83312888 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81976480 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80943500 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80919438 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.80910274 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79340903 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78841317 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76346377 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76029240 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.74198390 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74197407 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73173881 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72798828 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.72194084 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71605628 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71603522 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71386239 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70678211 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68183430 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66494763 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66382100 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65243826 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64148939 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63951126 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63038497 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62582973 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62275941 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.61765938 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61524164 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61335797 |
| 108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60871007 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58745830 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58665666 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58437480 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58425727 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57747450 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.57234987 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57225642 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56777202 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56492487 |
| 118 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55950072 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.55913874 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.55882972 |
| 121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54262593 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53702533 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53154635 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51174455 |
| 125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50551964 |
| 126 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49646484 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.48634834 |
| 128 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47894639 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47609199 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47260770 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.45522343 |
| 132 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45182376 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44942258 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44101630 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41707369 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.40683799 |
| 137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40213865 |
| 138 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39956965 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38726060 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38306785 |
| 141 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38084634 |
| 142 | Malaria_Homo sapiens_hsa05144 | 0.37626813 |
| 143 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35838896 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35075829 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33864704 |
| 146 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33077155 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32824702 |
| 148 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32297039 |
| 149 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32190831 |
| 150 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31303781 |
| 151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30318141 |
| 152 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29396240 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.29344232 |
| 154 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22880854 |
| 155 | Mineral absorption_Homo sapiens_hsa04978 | 0.18494847 |

